Dr. Vivek Lal
speaker
549 appearances
1 recordings
1 series
first heard Aug 2026
last heard 4 Aug
Dr. Vivek Lal’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Aug 2026 with 1.
Appearances
It's essentially a protease which breaks down collagen anywhere, right?
Amen.
And, you know, lungs have a lot of collagen.
If you break down the collagen with MMP9, there's something called a tripeptide ACPGP, which is created.
That dries neutrophils and creates neutrophilic inflammation.
And it's such a cyclic process.
Once that starts, it doesn't stop.
The main pathological signal in COPD and bronchiectasis and neutrophilic asthma and several neutrophilic diseases, sinusitis, is the MMP9 pathway.
And guess what these bacterias are doing?
So that is the primary pathway.
You give these bacteria cocktail.
that we have the res biotic, res B lung support, three bacteria cocktail, MMP9 pathway is downregulated.
So we are using these bacteria as a drug to downregulate MMP9, downregulate ACPGP, and downregulate neutrophilic inflammation.
And that's how the anti-inflammatory effect is happening in the lungs.
Absolutely.
Absolutely.
That is why next we're going to longevity and we're using the same pathways, same bacteria in a different application because you need to balance what you give for what organ, right?
So MMP9 pathway is so relevant, not just for lungs.
I'm just saying lungs because we have studied that the most, but different organisms.
Absolutely.
Showing 181–200 of 549 · page 10 of 28
← Previous
Next →